Proteomics to the people
The EU-funded PRIME-XS (Proteomics research infrastructure maximising knowledge exchange and access (XS)) consortium provided access to proteomics infrastructure to the European biomedical research community. Twelve leading centres in the field of proteomics from nine countries are developing new methods and tools and making their facilities available to researchers. The project received nearly 150 applications for proteomics research projects from 23 European countries, 122 of which were approved. In total, PRIME-XS provided more than 2 200 days of access to proteomics facilities over 4 years. In addition, PRIME-XS oversaw research to address bottlenecks in proteomic technology. Researchers streamlined information handling, processing of protein interaction networks and post-translational modifications, and the search for novel disease biomarkers. Completed technologies were transferred to the access sites and made available to life science researchers working at those facilities. Finally, the project provided a number of training workshops, meetings and courses to improve proteomics research knowledge in Europe. The research enabled by PRIME-XS was published in over 200 scientific publications. The consortium has supported proteomics research and provided the basis for information access and sharing in the proteomics community beyond the lifespan of the project.
Keywords
Proteomics, life science, research infrastructure, biomedical
